Physico-chemical features and toxicity-associated pathways

No Pathway Network information available for Physico-chemical features and toxicity-associated pathways

Pathways in the Physico-chemical features and toxicity-associated pathways SuperPath

#	Name	Source	Genes
1	Physico-chemical features and toxicity-associated pathways	WikiPathways	ACTA1 ACTR2 ACTR3 AKT1 APC AXIN1 CAMK1 CBL CDKN1A CDKN1B CTNNB1 DAAM1 DVL1 EGFR ELK1 ERBB2 ERBB4 FN1 FZD1 FZD10 FZD2 FZD3 FZD4 FZD5 FZD6 FZD7 FZD8 FZD9 GPX1 GRB2 GSK3B JUN MAP2K1 MAP2K4 MAPK1 MAPK8 MYC MYL1 MYLK MYLKP1 NCK1 NEFH NEFL NEFM NOS1 PAK1 PFN1 PFN2 PFN3 PFN4 PIK3CG PLCG1 PPP2CA PTK2 RAF1 RHOA ROCK2 SHC1 SOD1 SOS1 SRC STAT5A TGFA WNT11 WNT16 (see all 65) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	ROCK2	Rho Associated Coiled-Coil Containing Protein Kinase 2	Protein Coding	1
2	CBL	Cbl Proto-Oncogene	Protein Coding	1
3	FZD8	Frizzled Class Receptor 8	Protein Coding	1
4	FZD6	Frizzled Class Receptor 6	Protein Coding	1
5	FZD4	Frizzled Class Receptor 4	Protein Coding	1
6	AXIN1	Axin 1	Protein Coding	1
7	WNT11	Wnt Family Member 11	Protein Coding	1
8	TGFA	Transforming Growth Factor Alpha	Protein Coding	1
9	STAT5A	Signal Transducer And Activator Of Transcription 5A	Protein Coding	1
10	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	1
11	SOS1	SOS Ras/Rac Guanine Nucleotide Exchange Factor 1	Protein Coding	1
12	SOD1	Superoxide Dismutase 1	Protein Coding	1
13	SHC1	SHC Adaptor Protein 1	Protein Coding	1
14	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
15	ACTA1	Actin Alpha 1, Skeletal Muscle	Protein Coding	1
16	PTK2	Protein Tyrosine Kinase 2	Protein Coding	1
17	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	1
18	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	1
19	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	1
20	PPP2CA	Protein Phosphatase 2 Catalytic Subunit Alpha	Protein Coding	1
21	PLCG1	Phospholipase C Gamma 1	Protein Coding	1
22	PIK3CG	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma	Protein Coding	1
23	PFN1	Profilin 1	Protein Coding	1
24	PAK1	P21 (RAC1) Activated Kinase 1	Protein Coding	1
25	NOS1	Nitric Oxide Synthase 1	Protein Coding	1
26	NEFL	Neurofilament Light Chain	Protein Coding	1
27	NEFH	Neurofilament Heavy Chain	Protein Coding	1
28	NEFM	Neurofilament Medium Chain	Protein Coding	1
29	NCK1	NCK Adaptor Protein 1	Protein Coding	1
30	MYLK	Myosin Light Chain Kinase	Protein Coding	1
31	MYL1	Myosin Light Chain 1	Protein Coding	1
32	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	1
33	RHOA	Ras Homolog Family Member A	Protein Coding	1
34	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
35	APC	APC Regulator Of Wnt Signaling Pathway	Protein Coding	1
36	GSK3B	Glycogen Synthase Kinase 3 Beta	Protein Coding	1
37	GPX1	Glutathione Peroxidase 1	Protein Coding	1
38	FZD2	Frizzled Class Receptor 2	Protein Coding	1
39	FN1	Fibronectin 1	Protein Coding	1
40	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	1
41	ERBB4	Erb-B2 Receptor Tyrosine Kinase 4	Protein Coding	1
42	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	1
43	EGFR	Epidermal Growth Factor Receptor	Protein Coding	1
44	DVL1	Dishevelled Segment Polarity Protein 1	Protein Coding	1
45	CTNNB1	Catenin Beta 1	Protein Coding	1
46	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	1
47	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
48	ACTR3	Actin Related Protein 3	Protein Coding	1
49	MYLKP1	Myosin Light Chain Kinase Pseudogene 1	Pseudogene	1
50	CAMK1	Calcium/Calmodulin Dependent Protein Kinase I	Protein Coding	1
51	FZD10	Frizzled Class Receptor 10	Protein Coding	1
52	ACTR2	Actin Related Protein 2	Protein Coding	1
53	FZD9	Frizzled Class Receptor 9	Protein Coding	1
54	FZD7	Frizzled Class Receptor 7	Protein Coding	1
55	FZD1	Frizzled Class Receptor 1	Protein Coding	1
56	FZD3	Frizzled Class Receptor 3	Protein Coding	1
57	FZD5	Frizzled Class Receptor 5	Protein Coding	1
58	MAP2K4	Mitogen-Activated Protein Kinase Kinase 4	Protein Coding	1
59	PFN2	Profilin 2	Protein Coding	1
60	WNT16	Wnt Family Member 16	Protein Coding	1
61	PFN4	Profilin Family Member 4	Protein Coding	1
62	PFN3	Profilin 3	Protein Coding	1
63	GRB2	Growth Factor Receptor Bound Protein 2	Protein Coding	1
64	DAAM1	Dishevelled Associated Activator Of Morphogenesis 1	Protein Coding	1
65	ELK1	ETS Transcription Factor ELK1	Protein Coding	1

Disorders associated with Physico-chemical features and toxicity-associated pathways SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Noonan syndrome and noonan-related syndrome	Enrichment	CBL, MAP2K1, RAF1, SOS1	6.20
2	Colorectal cancer	Enrichment	AKT1, APC, CTNNB1, ERBB2, FZD3, SRC	5.45
3	Noonan syndrome 1	Enrichment	CBL, MAP2K1, RAF1, SOS1	5.40
4	Rasopathy	Enrichment	CBL, MAP2K1, RAF1, SOS1	5.18
5	Ovarian cancer	Enrichment	AKT1, APC, CDKN1B, CTNNB1, EGFR, ERBB2	5.07
6	Bladder cancer	Enrichment	CDKN1A, CTNNB1, EGFR, ERBB2	4.98
7	Lung non-small cell carcinoma	Enrichment	EGFR, ERBB2, MAP2K1	4.77
8	Desmoid disease, hereditary	Enrichment	APC, CTNNB1	4.17
9	Desmoid tumor	Enrichment	APC, CTNNB1	4.17
10	Robinow syndrome, autosomal dominant 1	Enrichment	DVL1, FZD2	3.87
11	Craniopharyngioma	Enrichment	APC, CTNNB1	3.87
12	Autosomal dominant robinow syndrome	Enrichment	DVL1, FZD2	3.87
13	Hepatocellular carcinoma	Enrichment	APC, AXIN1, CTNNB1	3.82
14	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Enrichment	ERBB4, NEFH, PFN1, SOD1	3.78
15	Exudative vitreoretinopathy 1	Enrichment	CTNNB1, FZD4	3.65
16	Robinow syndrome, autosomal recessive 1	Enrichment	DVL1, FZD2	3.65
17	Robinow syndrome, autosomal dominant 2	Enrichment	DVL1, FZD2	3.65
18	Autosomal recessive robinow syndrome	Enrichment	DVL1, FZD2	3.48
19	Breast cancer	Enrichment	AKT1, APC, JUN, SHC1	3.34
20	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A, CDKN1B	3.33
21	Noonan syndrome 3	Enrichment	RAF1, SOS1	3.33
22	Exudative vitreoretinopathy	Enrichment	CTNNB1, FZD4	3.21
23	Adult hepatocellular carcinoma	Enrichment	AXIN1, CTNNB1	3.10
24	Amyotrophic lateral sclerosis 1	Enrichment	NEFH, SOD1	3.00
25	Medulloblastoma	Enrichment	APC, CTNNB1	2.70
26	Lung cancer susceptibility 3	Enrichment	EGFR, ERBB2	2.70
27	Hepatoblastoma	Enrichment	APC, CTNNB1	2.35
28	Proteus syndrome	Enrichment	AKT1	2.32
29	Paget disease, extramammary	Enrichment	ERBB2	2.32
30	Pyloric stenosis, infantile hypertrophic, 1	Enrichment	NOS1	2.32
31	Nail disorder, nonsyndromic congenital, 1	Enrichment	FZD6	2.32
32	Noonan syndrome 5	Enrichment	RAF1	2.32
33	Noonan syndrome 4	Enrichment	SOS1	2.32
34	Congenital myopathy 2a, typical, autosomal dominant	Enrichment	ACTA1	2.32
35	Melorheostosis, isolated	Enrichment	MAP2K1	2.32
36	Omodysplasia 2	Enrichment	FZD2	2.32
37	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.32
38	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.32
39	Amyotrophic lateral sclerosis 18	Enrichment	PFN1	2.32
40	Myopathy, scapulohumeroperoneal	Enrichment	ACTA1	2.32
41	Charcot-marie-tooth disease, demyelinating, type 1f	Enrichment	NEFL	2.32
42	Caudal duplication anomaly	Enrichment	AXIN1	2.32
43	Visceral neuropathy, familial, 2, autosomal recessive	Enrichment	ERBB2	2.32
44	Charcot-marie-tooth disease, axonal, type 2cc	Enrichment	NEFH	2.32
45	Noonan syndrome 13	Enrichment	MAPK1	2.32
46	Charcot-marie-tooth disease, dominant intermediate g	Enrichment	NEFL	2.32
47	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	Enrichment	PAK1	2.32
48	Immune dysregulation, autoimmunity, and autoinflammation	Enrichment	PLCG1	2.32
49	Melorheostosis	Enrichment	MAP2K1	2.32
50	Neuroendocrine tumor	Enrichment	CDKN1B	2.32
51	Leopard syndrome 2	Enrichment	RAF1	2.32
52	Glutathione peroxidase deficiency	Enrichment	GPX1	2.32
53	Charcot-marie-tooth disease type 1f	Enrichment	NEFL	2.32
54	Congenital myopathy 2b, severe infantile, autosomal recessive	Enrichment	ACTA1	2.32
55	Cowden syndrome 6	Enrichment	AKT1	2.32
56	Amyotrophic lateral sclerosis 19	Enrichment	ERBB4	2.32
57	Microphthalmia/coloboma 11	Enrichment	FZD5	2.32
58	Immunodeficiency 97 with autoinflammation	Enrichment	PIK3CG	2.32
59	Thrombocytopenia 6	Enrichment	SRC	2.32
60	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies	Enrichment	RHOA	2.32
61	Congenital myopathy 2c, severe infantile, autosomal dominant	Enrichment	ACTA1	2.32
62	Congenital myopathy 14	Enrichment	MYL1	2.32
63	Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies	Enrichment	RHOA	2.32
64	Trigonitis	Enrichment	RAF1	2.32
65	Craniometadiaphyseal osteosclerosis with hip dysplasia	Enrichment	AXIN1	2.32
66	Adenoid ameloblastoma	Enrichment	CTNNB1	2.32
67	Charcot-marie-tooth disease type 2b5	Enrichment	NEFL	2.32
68	Familial adenomatous polyposis	Enrichment	APC	2.32
69	Zebra body myopathy	Enrichment	ACTA1	2.32
70	Gardner syndrome	Enrichment	APC	2.32
71	5q22 microdeletion syndrome	Enrichment	APC	2.32
72	Actin-accumulation myopathy	Enrichment	ACTA1	2.32
73	Attenuated familial adenomatous polyposis	Enrichment	APC	2.32
74	Serous carcinoma of the corpus uteri	Enrichment	ERBB2	2.32
75	Microcystic stromal tumor	Enrichment	CTNNB1	2.32
76	Hydrops fetalis, nonimmune	Enrichment	ACTA1, FZD6	2.17
77	Burkitt lymphoma	Enrichment	MYC	2.02
78	Fibromatosis, gingival, 1	Enrichment	SOS1	2.02
79	Spondyloepimetaphyseal dysplasia, strudwick type	Enrichment	FN1	2.02
80	Spondylometaphyseal dysplasia, corner fracture type	Enrichment	FN1	2.02
81	Osteopathia striata with cranial sclerosis	Enrichment	CTNNB1	2.02
82	Ovarian germ cell cancer	Enrichment	CBL	2.02
83	Pulmonic stenosis	Enrichment	SOS1	2.02
84	Hereditary motor and sensory neuropathy, type iic	Enrichment	NEFH	2.02
85	Robinow syndrome, autosomal dominant 3	Enrichment	FZD2	2.02
86	Multiple endocrine neoplasia, type iv	Enrichment	CDKN1B	2.02
87	Childhood hepatocellular carcinoma	Enrichment	CTNNB1	2.02
88	Spastic tetraplegia and axial hypotonia, progressive	Enrichment	SOD1	2.02
89	Periampullary adenoma	Enrichment	APC	2.02
90	Gastric adenocarcinoma and proximal polyposis of the stomach	Enrichment	APC	2.02
91	Houge-janssens syndrome 3	Enrichment	PPP2CA	2.02
92	Juvenile nasopharyngeal angiofibroma	Enrichment	CTNNB1	2.02
93	Malignant germ cell tumor of ovary	Enrichment	CBL	2.02
94	Teratoma	Enrichment	CTNNB1	2.02
95	Non-immune hydrops fetalis	Enrichment	ACTA1, FZD6	2.02
96	Lung cancer	Enrichment	EGFR, ERBB2	1.99
97	Glomerulopathy with fibronectin deposits 2	Enrichment	FN1	1.84
98	Nuchal bleb, familial	Enrichment	SOS1	1.84
99	Langerhans cell histiocytosis	Enrichment	MAP2K1	1.84
100	Neurodevelopmental disorder with spastic diplegia and visual defects	Enrichment	CTNNB1	1.84
101	Aortic aneurysm, familial thoracic 7	Enrichment	MYLK	1.84
102	Cenani-lenz syndactyly syndrome	Enrichment	APC	1.84
103	Neonatal nephrocutaneous inflammatory syndrome	Enrichment	EGFR	1.84
104	Anus, imperforate	Enrichment	CTNNB1	1.84
105	Exudative vitreoretinopathy 7	Enrichment	CTNNB1	1.84
106	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	MYC	1.84
107	Nail disease	Enrichment	FZD6	1.84
108	Colon adenocarcinoma	Enrichment	APC	1.84
109	Neonatal inflammatory skin and bowel disease	Enrichment	EGFR	1.84
110	Apc-associated polyposis conditions	Enrichment	APC	1.84
111	Distal arthrogryposis	Enrichment	ACTA1, FZD3	1.76
112	Gastric cancer	Enrichment	APC, ERBB2	1.74
113	Hereditary breast carcinoma	Enrichment	AKT1, APC	1.73
114	Cardiofaciocutaneous syndrome 1	Enrichment	MAP2K1	1.72
115	Nemaline myopathy 2	Enrichment	ACTA1	1.72
116	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	Enrichment	MYLK	1.72
117	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.72
118	Pilomatrixoma	Enrichment	CTNNB1	1.72
119	Barrett esophagus	Enrichment	ERBB2	1.72
120	Alazami syndrome	Enrichment	CTNNB1	1.72
121	Cardiofaciocutaneous syndrome	Enrichment	MAP2K1	1.72
122	Retinopathy of prematurity	Enrichment	FZD4	1.72
123	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Enrichment	CBL	1.72
124	Noonan syndrome with multiple lentigines	Enrichment	RAF1	1.72
125	Idiopathic achalasia	Enrichment	NOS1	1.72
126	Eyelid coloboma	Enrichment	FZD5	1.72
127	Primary hyperparathyroidism	Enrichment	CDKN1B	1.72
128	Intermediate nemaline myopathy	Enrichment	ACTA1	1.72
129	Gingival fibromatosis	Enrichment	SOS1	1.72
130	Lens coloboma	Enrichment	FZD5	1.72
131	Visceral myopathy 1	Enrichment	MYLK	1.62
132	Congenital myopathy 3 with rigid spine	Enrichment	ACTA1	1.62
133	Norrie disease	Enrichment	FZD4	1.62
134	Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia	Enrichment	SOD1	1.62
135	Familial adenomatous polyposis 1	Enrichment	APC	1.62
136	Charcot-marie-tooth disease, axonal, type 2e	Enrichment	NEFL	1.62
137	Myeloproliferative neoplasm	Enrichment	CBL	1.62
138	Persistent hyperplastic primary vitreous	Enrichment	FZD4	1.62
139	Coloboma of choroid and retina	Enrichment	FZD5	1.62
140	Aggressive systemic mastocytosis	Enrichment	CBL	1.62
141	Severe congenital nemaline myopathy	Enrichment	ACTA1	1.62
142	Inherited cancer-predisposing syndrome	Enrichment	APC, CDKN1B, EGFR	1.60
143	Coloboma of optic nerve	Enrichment	FZD5	1.55
144	Cowden syndrome 1	Enrichment	EGFR	1.55
145	Weyers acrofacial dysostosis	Enrichment	CTNNB1	1.55
146	Hemihyperplasia, isolated	Enrichment	RHOA	1.55
147	Adrenocortical carcinoma	Enrichment	CTNNB1	1.55
148	Breast adenocarcinoma	Enrichment	AKT1	1.55
149	Lung squamous cell carcinoma	Enrichment	EGFR	1.55
150	Multicystic kidney dysplasia	Enrichment	FZD3	1.55
151	Typical nemaline myopathy	Enrichment	ACTA1	1.55
152	Multicystic dysplastic kidney	Enrichment	FZD3	1.55
153	Myelofibrosis	Enrichment	SRC	1.48
154	Squamous cell carcinoma, head and neck	Enrichment	EGFR	1.48
155	Coats disease	Enrichment	FZD4	1.48
156	Capillary malformation-arteriovenous malformation 1	Enrichment	MAP2K1	1.48
157	Motor neuron disease	Enrichment	SOD1	1.48
158	Gallbladder cancer	Enrichment	CTNNB1	1.48
159	Pilomyxoid astrocytoma	Enrichment	RAF1	1.48
160	Childhood-onset nemaline myopathy	Enrichment	ACTA1	1.48
161	Melanocytic nevus syndrome, congenital	Enrichment	RAF1	1.42
162	Glioma susceptibility 1	Enrichment	ERBB2	1.42
163	Arteriovenous malformation	Enrichment	MAP2K1	1.37
164	Colonic benign neoplasm	Enrichment	APC	1.37
165	Cowden syndrome	Enrichment	AKT1	1.37
166	Familial thoracic aortic aneurysm and dissection	Enrichment	MYLK	1.37
167	Cat eye syndrome	Enrichment	FZD5	1.33
168	Myopathy, x-linked, with excessive autophagy	Enrichment	MAP2K1	1.33
169	Nemaline myopathy	Enrichment	ACTA1	1.33
170	Specific learning disability	Enrichment	MAPK1	1.29
171	Juvenile myelomonocytic leukemia	Enrichment	CBL	1.25
172	Meningioma	Enrichment	AKT1	1.25
173	Lip and oral cavity carcinoma	Enrichment	EGFR	1.25
174	Dilated cardiomyopathy	Enrichment	ACTA1, RAF1	1.25
175	Aortic valve disease 1	Enrichment	SOS1	1.22
176	Microphthalmia/coloboma 12	Enrichment	FZD5	1.22
177	Nk-cell enteropathy	Enrichment	ERBB4	1.22
178	Osteoporosis	Enrichment	SRC	1.19
179	Aortic aneurysm, familial thoracic 1	Enrichment	MYLK	1.19
180	46,xy partial gonadal dysgenesis	Enrichment	SOS1	1.19
181	Coloboma of macula	Enrichment	FZD5	1.16
182	Congenital myopathy 4a, autosomal dominant	Enrichment	ACTA1	1.16
183	Hydrocephalus	Enrichment	FZD3	1.16
184	Rhabdomyosarcoma	Enrichment	CBL	1.13
185	Gliosarcoma	Enrichment	EGFR	1.13
186	Polycystic liver disease	Enrichment	CTNNB1	1.11
187	Giant cell glioblastoma	Enrichment	EGFR	1.11
188	Autosomal dominant polycystic liver disease	Enrichment	CTNNB1	1.11
189	Heart, malformation of	Enrichment	MAPK1	1.08
190	Neuromuscular disease	Enrichment	ACTA1	1.08
191	Arteriovenous malformations of the brain	Enrichment	EGFR	1.06
192	Neuropathy, hereditary motor and sensory, okinawa type	Enrichment	NEFL	1.06
193	Congenital myopathy	Enrichment	ACTA1	1.06
194	Centronuclear myopathy	Enrichment	ACTA1	1.02
195	Tooth agenesis	Enrichment	TGFA	1.00
196	Precursor t-cell acute lymphoblastic leukemia	Enrichment	MYC	0.98
197	Cardiomyopathy, familial hypertrophic, 1	Enrichment	RAF1	0.96
198	Microcephaly	Enrichment	CTNNB1, MAPK1	0.93
199	Auditory neuropathy	Enrichment	NEFL	0.93
200	Hirschsprung disease 1	Enrichment	ERBB2	0.89
201	Peripheral nervous system disease	Enrichment	NEFL	0.85
202	Neuropathy	Enrichment	NEFL	0.85
203	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	0.83
204	Left ventricular noncompaction	Enrichment	RAF1	0.81
205	Fetal akinesia deformation sequence 1	Enrichment	ACTA1	0.79
206	Myopathy	Enrichment	ACTA1	0.76
207	Charcot-marie-tooth disease	Enrichment	NEFL	0.75
208	Nephrotic syndrome	Enrichment	FN1	0.73
209	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	MYLK	0.72
210	Sensorineural hearing loss	Enrichment	NEFL	0.69
211	Thrombocytopenia	Enrichment	SRC	0.69
212	Autosomal dominant non-syndromic intellectual disability	Enrichment	ERBB4	0.67
213	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	0.65
214	Congenital nervous system abnormality	Enrichment	CTNNB1	0.40
215	Nervous system disease	Enrichment	CTNNB1	0.40
216	Autism spectrum disorder	Enrichment	MAP2K1	0.39
217	Complex neurodevelopmental disorder	Enrichment	PPP2CA	0.35
218	Hereditary retinal dystrophy	Enrichment	FZD4	0.12
219	Fundus dystrophy	Enrichment	FZD4	0.12

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Physico-chemical features and toxicity-associated pathways

Pathway Network for Physico-chemical features and toxicity-associated pathways

Member Pathways for Physico-chemical features and toxicity-associated pathways

Pathways in the Physico-chemical features and toxicity-associated pathways SuperPath

Associated Genes for Physico-chemical features and toxicity-associated pathways

Associated Disorders for Physico-chemical features and toxicity-associated pathways

Disorders associated with Physico-chemical features and toxicity-associated pathways SuperPath

STRING Interaction Network for Physico-chemical features and toxicity-associated pathways

Sources for Physico-chemical features and toxicity-associated pathways